Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
Ed Cara
created: March 10, 2026, 7:15 p.m. | updated: March 11, 2026, 11:46 a.m.
The FDA ultimately ruled against approving leucovorin for autism, citing a lack of "sufficient data."
5 days, 22 hours ago: Gizmodo